Home | Welcome to Contract Pharma   
Last Updated Monday, September 22 2014
Print

Breaking News

Related Searches:
April 11, 2011
Biogen Idec achieved positive results from DEFINE, a Phase III trial to evaluate the investigational oral compound BG-12 (dimethyl fumarate) as a monotherapy in people with relapsing-remitting multiple sclerosis (RRMS).  Read More »
April 11, 2011
Johnson & Johnson received approval from the FDA for Invega (paliperidone) extended-release tablets for the treatment of schizophrenia in adolescents 12 to 17 years of age.  Read More »
April 8, 2011
Eisai Inc. has established a subsidiary in Brazil called Eisai Participaš§es Ltda. (Eisai Brazil), which will be based in Sao Paulo.  Read More »
April 8, 2011
Amgen has expanded its operations into Brazil with the acquisition of Bergamo, a privately held Brazilian pharmaceutical company, for approximately $215 million.   Read More »
April 8, 2011
Impax Laboratories has entered into a collaboration with Banner Pharmacaps to supply and commercialize two undisclosed softgel capsule products.  Read More »
April 8, 2011
Pharma’s French manufacturing sites in Le Vaudreuil and Val-de-Reuil have been registered as contract test labs for extractables testing with the FDA.  Read More »
April 8, 2011
NextPharma has installed a ModuC LS IPC encapsulation/over-encapsulation filling machine at its Clinical Trials Services Center in G÷ttingen, Germany.   Read More »
April 7, 2011
Pfizer and Zacharon Pharmaceuticals have entered into a strategic research collaboration to develop drugs for orphan diseases, including lysosomal storage disorders.  Read More »
April 7, 2011
AMRI and Parnell Manufacturing Pty Ltd. have entered into a development and commercial supply agreement, under which AMRI will provide process development, manufacturing and supply of APIs to support Parnell’s New Animal Drug Application (NADA) with  Read More »
April 7, 2011
GlaxoSmithKline and XenoPort, Inc. received approval from the FDA for Horizant (gabapentin enacarbil) Extended-Release Tablets for the treatment of moderate-to-severe primary Restless Legs Syndrome (RLS).  Read More »
April 7, 2011
OctoPlus N.V. has signed a feasibility agreement with a top-10 biopharmaceutical company to develop a controlled release formulation for an undisclosed peptide compound.   Read More »
April 7, 2011
Linda S. Mayer has been appointed president and chief executive officer of SCHOTT North America, Inc.   Read More »
April 6, 2011
Camargo Pharmaceutical Services has opened a new office in Research Triangle Park (RTP), NC in order to provide additional service offerings, as well as streamline client services.   Read More »
April 6, 2011
Aptiv Solutions has created an Adaptive Clinical Trials Innovation Center comprised of thought leaders and experts in adaptive trial design, methodology and implementation.   Read More »
April 6, 2011
Lupin Ltd. has granted Salix Pharmaceuticals, Ltd. exclusive worldwide rights (except for India) to use Lupin technology for all rifaximin products for human use.   Read More »

Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On